Zhou W, Liu H, Zhang F, Tang S, Zhu H, Lai M, Kalivas P W
Laboratory of Behavioral Neuroscience, Ningbo Addiction Research and Treatment Center, School of Medicine, Ningbo University, 42 Xibei Str., Ningbo 315010, PR China.
Neuroscience. 2007 Feb 23;144(4):1209-18. doi: 10.1016/j.neuroscience.2006.11.013. Epub 2006 Dec 19.
The involvement of cholinergic transmission in heroin self-administration and the reinstatement of heroin-seeking was examined in rats trained to nose-poke for i.v. heroin. Systemic treatment with physostigmine, an inhibitor of acetylcholinesterase, modestly reduced the acquisition and rate of heroin self-administration, and this suppression of heroin intake was reversed by pretreatment with scopolamine but not by mecamylamine. Following 10-14 days of self-administration, rats were left in the home environment for 14 days. Subsequently, rats were evaluated for extinction of nose-pokes during the first hour after being returned to the self-administration apparatus. One hour later a conditioned stimulus (house light, light in the nose-poke hole, sound of the infusion pump) was presented to initiate cue-induced reinstatement. Physostigmine produced a dose-dependent inhibition of cue-induced reinstatement, but only the dose of 0.5 mg/kg significantly decreased nose-poke responding in the extinction test. Chronic treatment with physostigmine (0.1 mg/kg) did not impair performance during acquisition of heroin self-administration. However, during a subsequent reinstatement test conducted in the absence of physostigmine pretreatment, heroin seeking was significantly below that of rats chronically pretreated with saline. To evaluate brain regions mediating the effects of systemic drug treatment on reinstatement, physostigmine was microinjected into the nucleus accumbens (NAc) or ventral tegmental area (VTA). Microinjection of physostigmine into the NAc prior to presenting conditioned cues inhibited the reinstatement of heroin-seeking, without affecting extinction responding. In contrast, microinjection of physostigmine into the VTA augmented the reinstatement induced by conditioned cues and extinction responding. Inactivation of either NAc or VTA by microinjecting tetrodotoxin blocked both extinction responding and cue-induced reinstatement. These data demonstrate that cholinergic transmission influences heroin self-administration and reinstatement. Moreover, cue-induced reinstatement was inhibited by physostigmine in the NAc and potentiated by cholinergic stimulation in the VTA.
在训练通过鼻触来静脉注射海洛因的大鼠中,研究了胆碱能传递在海洛因自我给药及复吸中的作用。用乙酰胆碱酯酶抑制剂毒扁豆碱进行全身治疗,适度降低了海洛因自我给药的习得和速率,而这种对海洛因摄入量的抑制可被东莨菪碱预处理逆转,但不能被美加明逆转。在自我给药10 - 14天后,将大鼠置于饲养环境中14天。随后,在大鼠返回自我给药装置后的第一小时,评估其鼻触行为的消退情况。一小时后,呈现条件刺激(饲养箱灯光、鼻触孔灯光、输液泵声音)以引发线索诱导的复吸。毒扁豆碱产生了剂量依赖性的线索诱导复吸抑制作用,但只有0.5毫克/千克的剂量在消退试验中显著降低了鼻触反应。用毒扁豆碱(0.1毫克/千克)进行慢性治疗在海洛因自我给药的习得过程中不损害表现。然而,在随后在没有毒扁豆碱预处理的情况下进行的复吸试验中,觅求海洛因的行为显著低于用生理盐水进行慢性预处理的大鼠。为了评估介导全身药物治疗对复吸作用的脑区,将毒扁豆碱微量注射到伏隔核(NAc)或腹侧被盖区(VTA)。在呈现条件线索之前将毒扁豆碱微量注射到NAc中可抑制觅求海洛因行为的复吸,而不影响消退反应。相反,将毒扁豆碱微量注射到VTA中增强了由条件线索诱导的复吸和消退反应。通过微量注射河豚毒素使NAc或VTA失活,阻断了消退反应和线索诱导的复吸。这些数据表明胆碱能传递影响海洛因自我给药和复吸。此外,线索诱导的复吸在NAc中被毒扁豆碱抑制,而在VTA中被胆碱能刺激增强。